Kaleido Biosciences Inc
KLDO
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.26K
Close$
Share Statistics
| Market cap | $4,262.00 |
|---|---|
| Enterprise Value | $4,262.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.16 |
| Beta | -1.17 |
| Outstanding Shares | 41,859,993 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
$91,667
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data